A registry based study on treatment and survival of Retinoblatoma diagnosed children patients from different parts of the world
Not Applicable
Completed
- Conditions
- Health Condition 1: null- All Retinobloastoma patients who were offered/received treatment of any type (i.e. focal therapy, surgery, chemotherapy, radiotherapy,palliative approach (i.e. no intervention)).
- Registration Number
- CTRI/2018/07/014693
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 52
Inclusion Criteria
Participating center: in which treatment-naïve Rb patients are seen and treated by any means. There is no lower or upper limit to the number of Rb patients seen in a center in order for it to become a participating center in the study. We are aiming to reach out and include as many Rb centers from around the world.
Subjects: All Rb patients that presented to a participating center from 01/01/2017-31/12/2017 and were offered/received treatment of any type (i.e. focal therapy, surgery, chemotherapy, radiotherapy, palliative approach (i.e. no intervention)).
Exclusion Criteria
Patients that presented following primary treatment given/offered elsewhere.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To report on the presentation mode of children diagnosed with Rb throughout the world, during 2017, with special attention to intra- versus extraocular disease presentation. <br/ ><br>Timepoint: 01/01/2017-31/12/2017 data to be collected
- Secondary Outcome Measures
Name Time Method ATimepoint: NA